BeOne Medicines AG

NasdaqGS:ONC Stock Report

Market Cap: US$39.3b

BeOne Medicines Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqGS:ONC Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
17 Nov 25SellUS$1,518,303Xiaobin WuIndividual3,991US$382.32
13 Nov 25SellUS$5,846,820Xiaobin WuIndividual16,009US$381.05
09 Sep 25BuyUS$3,034,068Capital Research and Management CompanyCompany67,875.63US$44.70
02 Sep 25SellUS$39,865Titus BallIndividual122US$326.76
11 Aug 25SellUS$15,891,389Capital Research and Management CompanyCompany55,078.47US$288.52
01 Aug 25SellUS$345,659Aaron RosenbergIndividual1,190US$290.47
30 Jul 25SellUS$280,233Chan LeeIndividual920US$304.60
23 Jun 25SellUS$830,360John OylerIndividual3,174US$262.90
23 Jun 25SellUS$354,380Xiaobin WuIndividual1,363US$260.00
23 Jun 25SellUS$267,280Wang LaiIndividual1,028US$260.00
17 Jun 25SellUS$374,473John OylerIndividual1,460US$256.49
17 Jun 25SellUS$567,742Xiaobin WuIndividual2,173US$266.22
17 Jun 25SellUS$118,142Wang LaiIndividual470US$251.37
16 Jun 25SellUS$112,463Chan LeeIndividual422US$266.50
16 Jun 25SellUS$979,046John OylerIndividual3,680US$266.05
16 Jun 25SellUS$313,558Wang LaiIndividual1,177US$266.40
11 Jun 25SellUS$34,620Titus BallIndividual134US$258.36
06 Jun 25SellUS$1,295,946John OylerIndividual5,127US$255.74
06 Jun 25SellUS$489,591Xiaobin WuIndividual1,934US$255.77
06 Jun 25SellUS$353,853Wang LaiIndividual1,402US$255.30
06 Jun 25SellUS$179,280Chan LeeIndividual700US$256.79
25 Mar 25SellUS$11,527,575Capital Research and Management CompanyCompany45,777.26US$251.82
04 Mar 25SellUS$2,073,826Xiaodong WangIndividual8,146US$257.41
28 Feb 25SellUS$190,535,020Baker Bros. Advisors LPCompany732,827US$260.00
21 Feb 25SellUS$1,286,174Wang LaiIndividual5,000US$260.17

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of ONC?
Owner TypeNumber of SharesOwnership Percentage
Private Companies368,3850.333%
Individual Insiders4,830,7794.37%
Hedge Funds8,799,0537.95%
Public Companies18,938,11917.1%
General Public29,744,66426.9%
Institutions47,943,74543.3%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 25 shareholders own 62.32% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
17.1%
Amgen Inc.
18,938,119US$6.7b0%no data
7.95%
Baker Bros. Advisors LP
8,799,053US$3.1b0%16.95%
5.15%
Capital Research and Management Company
5,698,256US$2.0b0.94%0.08%
4.77%
Hillhouse Investment Management, Ltd.
5,271,893US$1.9b0%8.27%
4.5%
PRIMECAP Management Company
4,980,581US$1.8b-1.97%1.23%
3.49%
John Oyler
3,858,922US$1.4b-4.4%no data
3.4%
FMR LLC
3,760,166US$1.3b0%0.06%
3.1%
BlackRock, Inc.
3,434,835US$1.2b0.66%0.01%
2.4%
The Vanguard Group, Inc.
2,653,796US$942.0m1.38%0.01%
2.04%
T. Rowe Price Group, Inc.
2,255,581US$800.7m-4.77%0.07%
1.34%
Norges Bank Investment Management
1,485,346US$527.2m0%0.03%
0.91%
Temasek Holdings (Private) Limited
1,011,464US$359.0m0%0.21%
0.71%
GF Fund Management Co., Ltd.
788,523US$279.9m-0.01%0.68%
0.71%
ICBC Credit Suisse Fund Management Co., Ltd
785,203US$278.7m0%1.42%
0.65%
Xiaodong Wang
716,430US$254.3m-4.35%no data
0.61%
Baillie Gifford & Co.
673,551US$239.1m-0.48%0.11%
0.57%
China Universal Asset Management Company Ltd.
630,290US$223.7m-0.12%1.1%
0.45%
Artal Group S.A.
500,000US$177.5m1.42%3.68%
0.41%
Teachers Insurance and Annuity Association-College Retirement Equities Fund
453,711US$161.1m0.01%0.03%
0.37%
Bosera Asset Management Co., Ltd.
414,640US$147.2m0%1.14%
0.35%
CSOP Asset Management Limited
386,326US$137.1m2.3%0.96%
0.33%
SDIC Chuangyi Industry Fund Management Co., Ltd.
368,385US$130.8m0%9.03%
0.33%
Guangzhou Economic Technology Development Zone Management Committee
368,385US$130.8m0%no data
0.32%
UBS Asset Management AG
353,109US$125.3m15.9%0.01%
0.32%
Geode Capital Management, LLC
352,187US$125.0m0.5%0.01%

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/02/18 15:23
End of Day Share Price 2026/02/17 00:00
Earnings2025/09/30
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

BeOne Medicines AG is covered by 72 analysts. 35 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Tianli WenAletheia Analyst Network Limited
Brian SkorneyBaird
Peter LawsonBarclays